Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.
about
Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiationc-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activationDifferential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamilyMolecular crosstalk between apoptosis, necroptosis, and survival signalingOnto better TRAILs for cancer treatmentRegulation of CD95/Fas signaling at the DISCMarine Drugs Regulating Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)Death receptor-ligand systems in cancer, cell death, and inflammationMechanisms of action of therapeutic antibodies for cancerA set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in lung cancer.TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitmentThe role of FADD in pancreatic cancer cell proliferation and drug resistanceThe linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death.Plasminogen activator urokinase expression reveals TRAIL responsiveness and supports fractional survival of cancer cells.TRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitroTRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKTDR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.Effect of hyperthermia in combination with TRAIL on the JNK-Bim signal transduction pathway and growth of xenograft tumors.TRAIL in cancer therapy: present and future challenges.Structural basis of LaDR5, a novel agonistic anti-death receptor 5 (DR5) monoclonal antibody, to inhibit DR5/TRAIL complex formationTRAIL-induced caspase/p38 activation is responsible for the increased catalytic and invasive activities of Akt.MEKK1/MEKK4 are responsible for TRAIL-induced JNK/p38 phosphorylationRIP1 expression is necessary for CD30-mediated cell death induction in anaplastic large-cell lymphoma cells.The role of TRADD in TRAIL-induced apoptosis and signaling.Regulating TRAIL receptor-induced cell death at the membrane : a deadly discussionTNF superfamily protein-protein interactions: feasibility of small- molecule modulationEnhancing apoptosis in TRAIL-resistant cancer cells using fundamental response rulesTargeted ovarian cancer treatment: the TRAILs of resistance.c-Myc primed mitochondria determine cellular sensitivity to TRAIL-induced apoptosis.TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.Proteasome inhibition can impair caspase-8 activation upon submaximal stimulation of apoptotic tumor necrosis factor-related apoptosis inducing ligand (TRAIL) signaling.STI571 reduces TRAIL-induced apoptosis in colon cancer cells: c-Abl activation by the death receptor leads to stress kinase-dependent cell death.Caspases leave the beaten track: caspase-mediated activation of NF-kappaB.Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling.Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme.TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.Distinct Activation Mechanisms of NF-κB Regulator Inhibitor of NF-κB Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP).
P2860
Q24307493-1F909A8A-EC9D-4440-8DB6-EC75F09D703BQ24607621-80A8BDF0-85CE-40A0-B3B9-87EE310FA3A0Q24654366-5C7B2663-C74B-4320-AE68-3F14342A0979Q26745680-F11A846B-C201-4248-BD9B-2240A977B82BQ26768160-9B7EA8E9-822F-4A6E-852D-2482A202902BQ26824629-4A0A3B84-1FA3-4839-B672-CC06350FF4C4Q26859211-7D58EE52-1688-4E4A-930F-CF5912E107E9Q26865568-CE61B6B7-D7D0-4A6B-885F-0D96534A19F8Q28385366-EACBCFE3-D7D9-4B5F-AB43-86376C14C13FQ30361915-F15B9E0E-735D-4F3A-8282-988799F7D982Q33523025-A881FBC4-4F42-431B-BE36-0971385BED2AQ33589801-781F93E4-2351-4922-B9A6-A27957283470Q33598878-ACF14C63-2A75-448A-83C3-2CB929CC155AQ33625907-E513551D-247E-43D4-BF56-D65633AA7A63Q33695003-AB200143-EA37-4DD7-B536-6F8280764435Q33802751-D90AC665-9BDE-49ED-B865-F18DDC69690EQ33912038-08135A6C-144E-43C6-9E9B-4CC52FF9CA7FQ33916314-FD7C4F53-FC07-4E8F-9D73-C14D485FB212Q33939106-3C4AC7E1-E3C5-49A1-916E-E91321357E3DQ33999606-51CF43FF-C97C-44AC-805E-126559C7DD54Q34257806-46B7E1A7-3A10-4422-9CF0-D3B8D2FBA37EQ34291312-F9ADE66E-DF1A-4693-9FBF-62C862487033Q34334395-8EEE00C0-4151-4C87-96ED-430AF458C235Q34415685-C2378D3E-A9F5-44CC-8380-27A729879E62Q34585256-3A96D4F1-0930-4BA4-BAD2-4B0DD08164EEQ34643604-C294B700-054D-4856-A964-CAB007BF05F1Q34682495-149074BB-7EA6-4FF0-B278-911D7E34BAC2Q35480734-A8D07FB8-C5FB-40C9-806D-7E5C51EEF4B3Q35534271-5E556244-7603-448F-8DCF-146444E587DCQ35551640-90A5F2B7-DA13-4449-8E38-E63ED90DDD6BQ35609438-C979B393-80D2-49F8-8284-CE92FB6EDEA4Q35752871-112284CC-D9A3-42F2-BC85-31A398B42437Q35774778-1D0D5DE5-140B-4155-9720-C239A7B7C59BQ35922585-4340338D-62AB-46C6-943D-9FE0E9E62832Q35946035-7CCEE1A9-D069-4BFC-903B-26372039C09FQ36450945-474DAF06-29DB-4B03-8FC8-07CB8D53C3C7Q36562365-F3159D12-4730-4115-9772-8B09F0370C5FQ36614009-734B491D-9FD0-478E-B8BA-00F79304A63AQ36731174-F8ECA456-402F-4253-9DAC-37BD4024FEB0Q36755072-B61A061B-8168-499A-9B5D-B45A5BDC1626
P2860
Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Molecular determinants of kina ...... ted apoptosis-inducing ligand.
@en
type
label
Molecular determinants of kina ...... ted apoptosis-inducing ligand.
@en
prefLabel
Molecular determinants of kina ...... ted apoptosis-inducing ligand.
@en
P2093
P356
P1476
Molecular determinants of kina ...... ted apoptosis-inducing ligand.
@en
P2093
Avi Ashkenazi
Darcie Sharp
David Lawrence
Domagoj Vucic
Eugene Varfolomeev
Heather Maecker
P304
40599-40608
P356
10.1074/JBC.M509560200
P407
P577
2005-10-15T00:00:00Z